Odyssey Therapeutics ODTX Growth Metrics (2023-2026)

NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Odyssey Therapeutics Quarterly Growth Metrics

Periods 9 quarters
Latest Sep 2026

Odyssey Therapeutics growth metrics data for the quarter ended Sep 2026. These growth metrics cover 9 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2023 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ) 12.20%23.72%32.34%-43.99%-5.62%119.21%39.98%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 35.43%2.89%-13.45%53.35%62.20%
Revenue (QoQ) 9.29%-50.00%-89.68%
Revenue Growth (1y) 511.50%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.01M-0.23M-3.43M3.34M-0.96M-15.81M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.87M-0.31M-1.29M-16.86M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M857.00
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M644.00
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -5.91%-9.06%-25.63%-5.13%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) -26.12%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -10.62%-24.24%-40.44%
Operating Margin (QoQ) 0.01M-0.23M-3.43M
Operating Margin Growth (1y) 0.87M
Operating Income (QoQ)Op. Inc (QoQ) -4.42%-7.05%8.75%1.25%-5.31%-39.44%-2.16%
Operating Income Growth (1y)Op. Inc Growth (1y) -20.24%-0.72%-1.58%-32.32%-48.14%
Net Margin (QoQ) 0.01M-0.23M-3.15M
Net Margin Growth (1y) 0.97M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -4.34%-7.29%14.00%5.49%-14.16%-37.96%-0.51%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -8.85%9.02%0.45%-28.02%-49.62%
Net Income (QoQ) -6.97%-7.29%14.00%5.49%-14.16%-37.96%-0.51%
Net Income Growth (1y) -24.51%6.73%0.45%-28.02%-49.62%
Net Cash Flow (QoQ)NCF (QoQ) -121.83%2,609.71%-205.20%93.07%26.88%903.76%-103.09%
Net Cash Flow Growth (1y)NCF Growth (1y) 358.56%-139.97%-33.88%-57.12%98.74%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -108.83%-7.05%-82.51%95.51%-131.68%30.28%-70.27%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -110.43%81.69%79.68%86.77%87.66%
Income After Tax (QoQ) -6.97%-7.29%14.00%5.49%-14.16%-37.96%-0.51%
Income After Tax Growth (1y) -24.51%6.73%0.45%-28.02%-49.62%
Free Cash Flow (QoQ)FCF (QoQ) -16.24%13.30%8.71%26.23%-78.34%15.76%-21.19%
Free Cash Flow Growth (1y)FCF Growth (1y) -49.32%32.13%-4.13%-1.18%-34.31%
FCF Margin (QoQ) -0.01M-0.15M-2.80M
FCF Margin Growth (1y) 0.60M
EPS (Diluted) (QoQ) 24.97%73.66%5.49%8.00%74.23%36.62%
EPS (Diluted) Growth (1y) 82.82%94.10%85.80%
EPS (Basic) (QoQ) 24.97%73.66%5.49%8.00%74.23%36.62%
EPS (Basic) Growth (1y) 82.82%94.10%85.80%
EBT (QoQ) -6.72%-7.60%13.80%2.71%-10.54%-38.21%-0.41%
EBT Margin (QoQ) 0.00M-0.23M-3.16M
EBT Margin Growth (1y) 0.80M
EBT Growth (1y) -24.77%3.70%0.25%-28.13%-49.25%
EBIT (QoQ) -4.42%-7.05%8.75%1.25%-5.31%-39.44%-2.16%
EBIT Margin (QoQ) 0.01M-0.23M-3.43M
EBIT Margin Growth (1y) 0.87M
EBIT Growth (1y) -20.24%-0.72%-1.58%-32.32%-48.14%
EBITDA Margin (QoQ) 0.04M-0.25M-3.32M
EBITDA Margin Growth (1y) 0.84M
Cash from Operations (QoQ)Cash from Ops. (QoQ) -12.64%11.29%8.77%18.97%-62.01%15.91%-20.38%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -33.67%26.13%-6.25%-0.72%-32.90%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -27.61%-31.71%-841.91%106.67%201.94%-707.56%120.47%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 160.01%-75.55%1.98%-1,007.29%125.04%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 49.96%-7.14%196.85%-69.62%-15.82%-14.32%129.66%-1.69%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) -44.29%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -78.20%12.54%25.58%-29.51%-34.95%-49.67%62.83%
Capital Expenditures (QoQ)Capex (QoQ) 449.81%-96.87%65.52%-4,758.33%106.62%25.68%170.97%
Capital Expenditures Growth (1y)Capex Growth (1y) 90.75%-743.77%-84.03%541.38%950.00%
Assets (QoQ) -10.88%-15.09%111.22%-9.46%
Assets Growth (3y) -5.25%
Assets Growth (1y) -9.66%-31.09%36.65%

Odyssey Therapeutics Growth Metrics API

Pull Odyssey Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ODTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY